Guidelines

Inflammatory Bowel Disease
Crohn’s Disease
Ulcerative Colitis Disease

Inflammatory Bowel Disease

Asian Organization for Crohn’s and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti‐tumor necrosis factor treatment. Part 1: Risk Assessment, and Part 2: Management

2017 The Asian Organization for Crohn’s and Colitis and the Asia Pacific Association of Gastroenterology have developed a set of consensus statements about risk assessment, detection and prevention of latent TB infection. Part 1: Risk Assessment.
2017 The Asian Organization for Crohn’s and Colitis and the Asia Pacific Association of Gastroenterology have developed a set of consensus statements about management of active TB infection in patients with inflammatory bowel disease (IBD) receiving anti‐TNF treatment. Part 2: Management.

Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic

2020 The COVID-19 pandemic, secondary to SARS-CoV-2, has resulted in high mortality and morbidity worldwide. As inflammatory bowel disease (IBD) is a chronic disease, and most patients are on long-term immunosuppressive agents, there is understandable concern, particularly in terms of therapy.
2020 The COVID-19 pandemic, secondary to SARS-CoV-2, has resulted in high mortality and morbidity worldwide. Patients with IBD may be immunosuppressed due to chronic illness, malnutrition and long-term immunosuppressive therapy. The APAGE presents guidelines on IBD management during the COVID-19 pandemic.

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

2019 The British Society of Gastroenterology (BSG) Clinical Services and Standards Committee (CSSC) commissioned a new guideline for the management of IBD in adults due to the major advances in investigations, pharmacological, non-pharmacological and surgical interventions for both ulcerative colitis and Crohn’s disease in the past decade.

COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients

2020 In these guidelines, IOIBD partnered with the European Crohn’s and Colitis Organisation (ECCO) to provide the most up-to-date information, and recommendations regarding the various dimensions of IBD care, especially during the COVID-19 pandemic.

Japanese Society of Gastroenterology Evidence-based Clinical Practice Guidelines for Inflammatory Bowel Disease

2018 The Japanese Society of Gastroenterology updated its evidence-based clinical practice guidelines for ulcerative colitis (UC) and Crohn’s disease (CD).

Crohn’s Disease

ACG Clinical Guideline: Management of Crohn’s Disease in Adults

2018 The American College of Gastroenterology provide recommendations for the diagnosis and treatment of patients with Crohn’s disease, which has evolved since the last practice guideline was published.

American Gastroenterological Association Institute Guideline on the Management of Crohn’s Disease After Surgical Resection

2016 The American Gastroenterological Association (AGA) official recommendations on the management of Crohn’s disease (CD) after surgical resection. These guidelines were developed to outline strategies to reduce disease recurrence in patients who have achieved remission following bowel resection.

ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment

2020 ECCO produces and regularly updates several guidelines aimed at providing evidence-based guidance on critical aspects of IBD care to all health care professionals who manage patients with IBD.

ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment

2019 ECCO provides an interdisciplinary framework with the present evidence-based consensus guidelines, which focus on surgery for CD, including preoperative aspects and drug management before surgery.

ECCO-EFCCA Patient Guidelines on Crohn’s Disease (CD)

2017 ECCO-EFCCA Patient Guidelines on CD was developed through a thorough process involving leading European physician experts and assessing all current evidence for the best management of patients with CD.

Ulcerative Colitis Disease

AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis

2019 The American Gastroenterological Association (AGA) present this practice guideline on the management of mild-to-moderate ulcerative colitis (UC). It is a compilation of the clinical evidence on which these recommendations were formulated

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

2020 AGA present this practice guideline on the management of moderate-to-severe ulcerative colitis (UC). It is a compilation of the clinical evidence on which these recommendations were formulated.

ACG Clinical Guideline: Ulcerative Colitis in Adults

2019 The American College of Gastroenterology (ACG) presents these clinical guidelines for UC. The scientific evidence for these guidelines was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) process.

ECCO-EFCCA Patient Guidelines on Ulcerative Colitis (UC)

2017 The ECCO and EFCCA assembled the expertise of the best specialist in different disciplines to generate this referential document covering diagnosis and management of UC.

Inflammatory Bowel Disease

Crohn’s Disease

Ulcerative Colitis Disease

Contact Us

Send us a message